Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia

被引:0
作者
Kilinc, Suna [1 ]
Bostan, Ozlem [2 ]
Erol, Meltem [2 ]
Erturk, Saide [3 ]
Dilek, Damla [2 ]
Yigit, Ozgul [2 ]
机构
[1] Istanbul Bagcilar Training & Res Hosp, Dept Pediat Endocrinol, Istanbul, Turkey
[2] Istanbul Bagcilar Training & Res Hosp, Dept Pediat, Istanbul, Turkey
[3] Istanbul Esenler Obstet & Pediat Hosp, Dept Pediat, Istanbul, Turkey
关键词
Bisphosphonates; hypercalcemia; miliary tuberculosis; pamidronate-disodium; VITAMIN; CALCIUM;
D O I
10.14744/nci.2019.14890
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercalcemia is a common metabolic abnormality in children and generally occurs due to hyperparathyroidism, vitamin D toxicity, some genetic disorders and malignant diseases. Granulomatous diseases are a rare cause of hypercalcemia in children, which are usually mild and asymptomatic. Severe hypercalcemia in granulomatous diseases has also been reported in the literature. Here, we report a child presenting with severe hypercalcemia secondary to miliary tuberculosis with successful management with bisphosphonate treatment. Increased 1,25(OH)2D3 synthesis by activated macrophages in the granuloma tissue is the major mechanism of hypercalcemia in tuberculosis.
引用
收藏
页码:411 / 414
页数:4
相关论文
共 50 条
  • [1] Severe Hypercalcemia in an Infant with Subcutaneous Fat Necrosis: Successful Management with Bisphosphonate Treatment
    Abali, Zehra Yavas
    Collu, Medis
    Poyrazoglu, Sukran
    Bas, Firdevs
    Darendeliler, Feyza
    JOURNAL OF CHILD - COCUK DERGISI, 2022, 22 (03): : 244 - 247
  • [2] Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate
    Tagiyev, Anar
    Demirbilek, Huseyin
    Tavil, Betul
    Buyukyilmaz, Gonul
    Gumruk, Fatma
    Cetin, Mualla
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (03) : 232 - 234
  • [3] EFFICACY AND SAFETY OF THE BISPHOSPHONATE TILUDRONATE FOR THE TREATMENT OF TUMOR-ASSOCIATED HYPERCALCEMIA
    DUMON, JC
    MAGRITTE, A
    BODY, JJ
    BONE AND MINERAL, 1991, 15 (03): : 257 - 266
  • [4] Administration of bisphosphonate for hypercalcemia associated with oral cancer
    Kojiro Onizawa
    Hiroshi Yoshida
    Head & Face Medicine, 2 (1)
  • [5] Bisphosphonate Versus Bisphosphonate and Calcitonin for the Treatment of Moderate to Severe Hypercalcemia of Malignancy
    Khan, Attiya A.
    Gurnani, Payal K.
    Peksa, Gary D.
    Whittier, William L.
    DeMott, Joshua M.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 277 - 285
  • [6] Tuberculosis-Associated Hemophagocytic Lymphohistiocytosis: A Review of Current Literature
    Fauchald, Trym
    Blomberg, Bjorn
    Reikvam, Hakon
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (16)
  • [7] SEVERE HYPERCALCEMIA ASSOCIATED WITH MILIARY TUBERCULOSIS
    CHAN, CHS
    CHAN, TYK
    SHEK, ACC
    MAK, TWL
    LUI, SF
    LAI, KN
    JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 97 (03): : 180 - 182
  • [8] Combined therapies with calcitonin and corticosteroids, or bisphosphonate, for treatment of hypercalcemia of malignancy
    Wimalawansa S.J.
    Journal of Bone and Mineral Metabolism, 1997, 15 (3) : 160 - 164
  • [9] The new bisphosphonate ibandronate in the treatment of tumor-induced hypercalcemia
    Herrmann, Z
    Schöter, KH
    ONKOLOGIE, 1999, 22 (03): : 208 - 211
  • [10] METHYLPENTYLAMINOPROPYLIDENEBISPHOSPHONATE (BM-21.0955) - A NEW POTENT AND SAFE BISPHOSPHONATE FOR THE TREATMENT OF CANCER-ASSOCIATED HYPERCALCEMIA
    WUSTER, C
    SCHOTER, KH
    THIEBAUD, D
    MANEGOLD, C
    KRAHL, D
    CLEMENS, MR
    GHIELMINI, M
    JAEGER, P
    SCHARLA, SH
    BONE AND MINERAL, 1993, 22 (02): : 77 - 85